Ruptured aneurysms | Unruptured aneurysms | |||||
Neurosurgical clipping (NSC) | Endovascular Therapy (EVT) | EVT+NSC | Neurosurgical Clipping (NSC) | Endovascular Therapy (EVT) | EVT+NSC | |
N | 18 601 | 26 955 | 1386 | 13 377 | 29 410 | 310 |
Age, year, mean±SD | 54.72±13.56 | 55,39±13.63 | 54.05±13.03 | 54.77±11.23 | 55.75±12.20 | 54.17±12.40 |
Sex: female | 65.65% | 66.40% | 69.26% | 71.69% | 72.22% | 72.90% |
Charlson Comorbidity Index | 0.41±0.64 | 0.41±0.64 | 0.43±0.63 | 0.27±0.37 | 0.29±0.57 | 0.34±0.65 |
Myocardial infarction | 0.07% | 0.12% | XXX | 0.15% | 0.16% | 0.00% |
Congestive heart failure | 0.38% | 0.38% | 0.29% | 0.29% | 0.39% | 0.00% |
Peripheral vascular disease | 0.03% | 0.02% | 0.00% | 0.11% | 0.08% | 0.00% |
Cerebrovascular disease | 29.87% | 29.76% | 32.03% | 14.71% | 16.83% | 21.61% |
Dementia | 0.30% | 0.34% | XXX | 0.18% | 0.21% | 0.00% |
Chronic pulmonary disease | 1.06% | 0.91% | 1.52% | 1.40% | 1.00% | 1.61% |
Connective tissue / rheumatic disease | 0.08% | 0.08% | 0.00% | 0.19% | 0.18% | 0.00% |
Peptic ulcer disease | 0.02% | XXX | 0.00% | XXX | XXX | 0.00% |
Mild liver disease | 0.92% | 0.76% | 1.15% | 0.68% | 0.41% | 0.97% |
Diabetes without complications | 0.63% | 0.68% | 0.58% | 1.99% | 1.65% | 1.29% |
Diabetes with complications | 0.03% | 0.03% | 0.00% | 0.07% | 0.06% | XXX |
Paraplegia and hemiplegia | 1.71% | 2.26% | 2.24% | 1.40% | 1.54% | 2.26% |
Renal disease | 0.73% | 0.55% | 0.65% | 0.87% | 0.69% | 0.97% |
Cancer | 0.27% | 0.27% | 0.29% | 0.51% | 0.37% | XXX |
Moderate or severe liver disease | 0.28% | 0.20% | XXX | 0.10% | 0.04% | 0.00% |
Metastatic carcinoma | 0.03% | 0.02% | 0.00% | 0.00% | 0.01% | 0.00% |
AIDS/HIV | 0.05% | 0.05% | 0.00% | XXX | 0.05% | 0.00% |
NIS-SSS | 15.46 | 14.78 | 17.49 | |||
NIS-SSS>7 | 79.79% | 63.64% | 79.58% |
EVT, endovascular treatment; NIS-SSS National Inpatient Sample-Subarachnoid hemorrhage Severity Score, NSC, neurosurgical clipping; SD, standard deviation